ArticleScientific reports2025
A predictive model for diagnosing peripheral pulmonary lesions using radial probe endobronchial ultrasound images.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Radial probe endobronchial ultrasound transbronchial lung biopsy with guide sheath (RP-EBUS-GS-TBLB) was one of the main diagnostic methods for peripheral pulmonary lesions (PPLs). The aim of this study was to develop a predictive model for the diagnostic rate of RP-EBUS-TBLB in PPLs. A total of 189 consecutive patients with PPLs who had undergone RP-EBUS-TBLB between January 2022 and October 2024 in 8th Medical Centre, Chinese PLA General Hospital were enrolled in this retrospective single-center cohort study. The LASSO regression method was used to select predictors and nomogram model was developed using multivariate logistic regression. Internal validation was performed using bootstrapping. Model performance was evaluated using the area under the curve (AUC), calibration curves, and decision curve analysis (DCA). Bootstrapping method was applied for internal validation. The diagnostic rate of RP-EBUS-TBLB in PPLs was 74.07% (140/189). Six (lesion morphology in CT, number of biopsies, size, margin, echogenicity and RP-EBUS location) variables were selected by the LASSO regression analysis. We applied EBUS imaging features (size, margin, echogenicity and RP-EBUS location; model 1) separately and combined them with clinical features (lesion morphology in CT and number of Biopsies; model 2) to develop two predictive models. The AUC of model 1 was 0.889 (95% CI, 0.826–0.943), and it was 0.917 (95% CI, 0.862–0.960) in model 2. The predictive model was well calibrated and DCA indicated its potential clinical usefulness. However, there is no significant difference in AUC between the two models, which suggest that the model 1(only using EBUS imaging features) can serve as a concise and efficient predictive model and has great potential to predict the diagnostic rate of RP-EBUS-TBLB in PPLs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.